Study #2021-0071
Longitudinal Assessment of Cardiovascular Injury and Cardiac Fitness in LA-NSCLC Patients Receiving Model Based Personalized Chemoradiation ? an Adaptive Cohort Registration Study
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study assesses cardiovascular injury and cardiac fitness in patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (locally advanced) receiving model based personalized chemoradiation. The goal of this study is to learn more about the risk of developing heart disease as a result of chemoradiation treatment for lung cancer. Researchers also want to learn if the risk can be reduced by using a patient's individual risk profile to guide cancer treatment and help protect the heart.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Locally Advanced Lung Non-Small Cell Carcinoma;Stage III Lung Cancer AJCC v8;Stage IIIA Lung Cancer AJCC v8;Stage IIIB Lung Cancer AJCC v8;Stage IIIC Lung Cancer AJCC v8
Study phase:
Phase I
Physician name:
Zhongxing Liao
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.